Reaction
Drug Delivery System Issue reporting signals
As of the last recalculation, Drug Delivery System Issue appears in 1,857 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE (PRR 152.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 132 | 152.4 | 154.3 |
| Budesonide And Formoterol Fumarate Dihydrate | 226 | 29.6 | 29.6 |
| Fremanezumab-Vfrm | 17 | 16.7 | 16.8 |
| Tiotropium Bromide Inhalation Spray | 14 | 14.1 | 14.1 |
| Prednisolone Acetate | 10 | 10.9 | 10.9 |
| Guselkumab | 30 | 9.5 | 9.5 |
| Budesonide | 44 | 8.5 | 8.6 |
| Benralizumab | 14 | 7.9 | 7.9 |
| Insulin Degludec | 13 | 6.2 | 6.2 |
| Guanfacine | 4 | 5.7 | 5.7 |
| Esketamine Hydrochloride | 8 | 5.0 | 5.0 |
| Somatropin | 32 | 4.9 | 5.0 |
| Methylphenidate | 11 | 4.3 | 4.3 |
| Abaloparatide | 11 | 4.2 | 4.2 |
| Faricimab | 3 | 4.2 | 4.2 |
| Ustekinumab | 31 | 3.4 | 3.4 |
| Erenumab-Aooe | 11 | 2.2 | 2.2 |
| Lifitegrast | 3 | 2.1 | 2.1 |
| Adapalene | 3 | 0.2 | 0.2 |